Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
Abroad (travel likely)RecruitingPHASE2
Conditions
Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8 · Triple-Negative Breast Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Vandana G. Abramson)
Study leads
Vandana G Abramson
Principal Investigator
Vanderbilt University/Ingram Cancer Center